Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore

被引:8
作者
Hackman, Jada [1 ]
Falade-Nwulia, Oluwaseun [2 ]
Patel, Eshan U. [3 ]
Mehta, Shruti H. [2 ]
Kirk, Gregory D. [2 ,4 ]
Astemborski, Jacquie [2 ]
Ray, Stuart C. [4 ]
Thomas, David L. [2 ,4 ]
Laeyendecker, Oliver [1 ,2 ,4 ]
机构
[1] NIAID, Div Intramural Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
Hepatitis C virus; 1CE; Phylogenetic; Molecular epidemiology; PWID; Injection drug use; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; HCV INFECTION; NEW-YORK; TRANSMISSION; USERS; HIV; PREVALENCE; VANCOUVER; NETWORK;
D O I
10.1016/j.meegid.2019.104078
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study examines correlates of hepatitis C virus (HCV) genetic clustering among community-recruited people who inject drugs enrolled in the AIDS Linked to the IntraVenous Experience cohort in Baltimore between 1988 and 1989. HCV RNA was extracted and the core/envelope-1 region was sequenced. Clusters were identified from maximum likelihood trees with 1000 bootstrap replicates using a 70% aLRT and a 4% genetic-distance threshold in Cluster Picker. Overall, 46% of participants were in a cluster, including 122 genotype-1a and 36 genotype-1b clusters with an average of 2-3 genetically linked HCV infections. The largest cluster consists of 9 participants. In univariable analysis, black race (PR= 1.66 [95% CI: 1.12-2.45]), age < 35 years (PR= 1.18 [95% CI: 1.02-1.37]), and injection drug use of cocaine alone (PR= 1.30 [95% CI: 1.02-1.65]) were significantly associated with being in a cluster. Conversely, a history of medication-associated treatment (MAT) was negatively associated with being in a cluster (PR= 0.82 [95% CI: 0.71-0.95]). In multivariable analysis, black race (APR = 1.62 [95% CI: 1.11-2.38]) remained independently associated being in a cluster while MAT (APR = 0.85 [95% CI: 0.74-0.99]) remained negatively associated with clustering. Our findings suggest strong locally-propagated transmission networks during the early epidemic that was driven by younger PWID. In light of the current opioid epidemic in the US, these findings suggest an urgent need for preventive interventions to mitigate the growth of large HCV transmission networks.
引用
收藏
页数:7
相关论文
共 51 条
  • [1] Young people and injection drug use: Is there a need to expand harm reduction services and support?
    Adamson, Kelly
    Jackson, Lois
    Gahagan, Jacqueline
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 39 : 14 - 20
  • [2] Agar Michael, 2002, Med Anthropol, V21, P115, DOI 10.1080/01459740212904
  • [3] Molecular epidemiology of hepatitis C virus in a social network of injection drug users
    Aitken, CK
    McCaw, RF
    Bowden, DS
    Tracy, SL
    Kelsall, JG
    Higgs, PG
    Kerger, MJ
    Nguyen, H
    Crofts, JN
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) : 1586 - 1595
  • [4] RISK-FACTORS FOR ACUTE NON-A, NON-B HEPATITIS IN THE UNITED-STATES AND ASSOCIATION WITH HEPATITIS-C VIRUS-INFECTION
    ALTER, MJ
    HADLER, SC
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    MOYER, LA
    FIELDS, HA
    BRADLEY, DW
    MARGOLIS, HS
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (17): : 2231 - 2235
  • [5] [Anonymous], [No title captured]
  • [6] [Anonymous], [No title captured]
  • [7] [Anonymous], [No title captured]
  • [8] NEW EVIDENCE ON INTRAVENOUS COCAINE USE AND THE RISK OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ANTHONY, JC
    VLAHOV, D
    NELSON, KE
    COHN, S
    ASTEMBORSKI, J
    SOLOMON, L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) : 1175 - 1189
  • [9] A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies
    Bartlett, S. R.
    Wertheim, J. O.
    Bull, R. A.
    Matthews, G. V.
    Lamoury, F. M. J.
    Scheffler, K.
    Hellard, M.
    Maher, L.
    Dore, G. J.
    Lloyd, A. R.
    Applegate, T. L.
    Grebely, J.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2017, 24 (05) : 404 - 411
  • [10] Transmission of Hepatitis C Virus among Prisoners, Australia, 2005-2012
    Bretana, Neil Arvin
    Boelen, Lies
    Bull, Rowena
    Teutsch, Suzy
    White, Peter A.
    Lloyd, Andrew R.
    Luciani, Fabio
    [J]. EMERGING INFECTIOUS DISEASES, 2015, 21 (05) : 765 - 774